Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
First generation antihistamine drug which is derived from ethylene diamine with important sedative and antimuscarinic effects. The anticholinergic effect may inhibit lactation.
At latest update no published data on excretion into breast milk was found.
Drug that is scarcely supported by bibliographical evidence, which is marketed in very few countries from Eastern Europe, Mexico ...
Until more published information about this drug regarding breastfeeding appears, it may be preferable the use of a known and safer alternative.